Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics

Talanta

Volumn 81, Issue 3, 2010, Pages 766-772

  Gu, Yan ^a,b   Zhang, Yifei ^c   Shi, Xianzhe ^b   Li, Xiaoying ^c   Hong, Jie ^c   Chen, Jing ^b   Gu, Weiqiong ^c   Lu, Xin ^b   Xu, Guowang ^b   Ning, Guang ^c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c University of Shanghai   (China)

Author keywords

Berberine; Dyslipidemia; Fatty acids; Metabonomics; Type 2 diabetes; UPLC MS

Indexed keywords

BODY FLUIDS; DISCRIMINANT ANALYSIS; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINE; METABOLITES; PATIENT TREATMENT; PATTERN RECOGNITION; SIGNAL PROCESSING;

BERBERINE; DYSLIPIDEMIAS; METABONOMICS; TYPE-2 DIABETES; UPLC/MS;

FATTY ACIDS;

BERBERINE; FATTY ACID; PLACEBO;

AGED; CHEMISTRY; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIAS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLOMICS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TANDEM MASS SPECTROMETRY;

AGED; BERBERINE; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DYSLIPIDEMIAS; FATTY ACIDS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MIDDLE AGED; PLACEBOS; TANDEM MASS SPECTROMETRY;

EID: 77949336458     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2010.01.015     Document Type: Article

References (33)

1. International Diabetes Federation, Diabetes Atlas, 3rd ed., 2006, Brussels.
2. Ning G., Hong J., Bi Y.F., Gu W.Q., Zhang Y.F., Zhang Z.G., Huang Y., Wang W.Q., and Li X.Y. J. Diabetes 1 (2009) 163-172
3. Ni Y.X. Zhong Xi Yi Jie He Za Zhi 8 (1988) 711-713 (article in Chinese)
4. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., and Kim J.B. Diabetes 55 (2006) 2256-2264
5. Leng S.H., Lu F.E., and Xu L.J. Acta Pharmacol. Sin. 25 (2004) 496-502
6. Xie P., Zhou H., and Gao Y. Chin. J. Clin. Healthc. 8 (2005) 402-403 (article in Chinese)
7. Wei J., Wu J., Jiang J., Wang S., and Wang Z. Zhong Xi Yi Jie He Ganbing Za Zhi 14 (2004) 334-336 (article in Chinese)
8. Zhang Y.F., Li X.Y., Zou D.J., Liu W., Yang J.L., Zhu N., Huo L., Wang M., Hong J., Wu P.H., Ren G.G., and Ning G. J. Clin. Endocrinol. Metab. 93 (2008) 2559-2565
9. Yin J., Hu R., Chen M., Tang J., Li F., Yang Y., and Chen J. Metabolism 51 (2002) 1439-1443
10. Zhou L., Yang Y., Wang X., Liu S., Shang W., Yuan G., Li F., Tang J., Chen M., and Chen J. Metabolism 56 (2007) 405-412
11. Yin J., Gao Z., Liu D., Liu Z., and Ye J. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E148-156
12. Nicholson J.K., Lindon J.C., and Holmes E. Xenobiotica 29 (1999) 1181-1189
13. Nicholson J.K., Connelly J., Lindon J.C., and Holmes E. Nat. Rev. Drug Discov. 1 (2002) 153-161
14. Griffin J.L., and Bollard M.E. Curr. Drug Metab. 5 (2004) 389-398
15. Yin P.Y., Zhao X.J., Li Q.R., Wang J.S., Li J.S., and Xu G.W. J. Proteome Res. 5 (2006) 2135-2143
16. Chert M.J., Su M.M., Zhao L.P., Jiang J., Liu P., Cheng J.Y., Lai Y.J., Liu Y.M., and Jia W. J. Proteome Res. 5 (2006) 995-1002
17. Ellis D.I., Dunn W.B., Griffin J.L., Allwood J.W., and Goodacre R. Pharmacogenomics 8 (2007) 1243-1266
18. Zhao X.J., Zhang Y., Meng X.L., Yin P.Y., Deng C., Chen J., Wang Z., and Xu G.W. J. Chromatogr. B 873 (2008) 151-158
19. Bao Y.Q., Zhao T., Wang X.Y., Qiu Y.P., Su M.M., Jia W.P., and Jia W. J. Proteome Res. 8 (2009) 1623-1630
20. Huo T.G., Cai S., Lu X.M., Sha Y., Yu M.Y., and Li F.M. J. Pharm. Biomed. Anal. 49 (2009) 976-982
21. Puttmann M., Krug H., Ochsenstein E.V., and Kattermann R. Clin. Chem. 39 (1993) 825-832
22. Eriksson L., Johansson E., Kettaneh-Wold N., and Wold S. Multi- and Megavariate Data Analysis (2001), Umetrics Academy pp. 43-56
23. Deng X.L., Li X.R., and Tian C.G. J. Nanjing Med. Univ. 19 (2005) 181-186
24. Boden G., Chen X.H., and Iqbal N. Diabetes 47 (1998) 1609-1612
25. Dobbins R.L., Chester M.W., Daniels M.B., McGarry J.D., and Stein D.T. Diabetes 47 (1998) 1613-1618
26. Unger R.H. Diabetes 44 (1995) 863-870
27. Boden G. Diabetes 46 (1997) 3-10
28. Mcgarry J.D., and Dobbins R.L. Diabetologia 42 (1999) 128-138
29. McGarry J.D. Diabetes 51 (2002) 7-18
30. Boden G., and Shulman G.I. Eur. J. Clin. Invest. 32 (2002) 14-23
31. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., and Shulman G.I. Diabetes 48 (1999) 1270-1274
32. Houstis N., Rosen E.D., and Lander E.S. Nature 440 (2006) 944-948
33. Schinner S., Scherbaum W.A., Bornstein S.R., and Barthel A. Diabet. Med. 22 (2005) 674-682